Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean
- Posted on September 15, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Gilead, PAHO agree on HIV prevention drug access in Latin America, Caribbean
Sept 15 (Reuters) - U.S. drugmaker Gilead Sciences said on Tuesday it had reached an agreement with the Pan American Health Organization to widen access to its HIV prevention drug across Latin America and the Caribbean, as the regions seek to curb new infections. Under the new agreement, countries that choose to offer lenacapavir, a twice-yearly drug marketed as Yeztugo in the United States for
